Things could have been totally different for Valeant Pharmaceuticals if former CEO Michael Pearson had stuck to his original guns about hedge fund billionaire Bill Ackman. Apparently, he didn't ...

Hedge fund billionaire Bill Ackman, founder of $12 ... far this year have been mostly dragged down by Valeant Pharmaceuticals' massive decline. Ackman is the largest hedge fund shareholder with ...

Bill Ackman, the billionaire founder of Pershing Square Capital, spent nearly four hours hosting a call defending his massive investment in Valeant Pharmaceuticals. Ackman has lost more than $1 ...

Bill Ackman is the founder and CEO of Pershing Square ... alleging that Pershing along with Valeant Pharmaceuticals had improperly traded before their 2014 takeover attempt of Allergan.

An analysis of Bill Ackman's presentation on Fannie Mae and Freddie Mac, cautioning investors on volatility and long-term ...

Bill Ackman Just Perfectly Executed The Heads I Win ... He bought more than 28 million shares in the company knowing he and Valeant were about to try to take it over. Even his critics acknowledged the ...

Now, Bill Ackman is one of the most popular hedge fund managers on Wall Street. He’s known for several popular trades such as Valeant, Herbalife, Howard Hughes, and even Restaurant Brands.

Bill Ackman is planning to take his investment firm ... He suffered a losing streak between 2015 and 2017 when big bets on ...

Billionaire investor Bill Ackman has been climbing the ranks of best investors to watch for much of the 21st century. Like most hedge funds, his returns have been volatile. For instance ...

Bill Ackman and his fund Pershing Square Capital Management are big fans of the real estate development company Howard Hughes Holdings (NYSE: HHH). In 2010, Pershing, along with several big ...

A $55 billion hostile takeover bid from Canada-based competitor Valeant and hedge fund manager Bill Ackman has turned into an ugly battle. A recent overture from a potential white knight may save ...

This advertisement has not loaded yet, but your article continues below. A rare display of a CEO bashing one his company’s largest investors 365 Bloor Street East, Toronto, Ontario, M4W 3L4 ...